Skip to main content

Advertisement

SpringerLink
Log in

The Neurobiology of Erythropoietin

  • Original Paper
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Agnello D, Bigini P et al (2002) Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 952(1):128–134

    Article  PubMed  CAS  Google Scholar 

  • Assandri R, Egger M et al (1999) Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. J Physiol 516(Pt 2):343–352

    Article  PubMed  CAS  Google Scholar 

  • Bernaudin M, Marti HH et al (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19(6):643–651

    Article  PubMed  CAS  Google Scholar 

  • Bernaudin M, Bellail A et al (2000) Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 30(3):271–278

    Article  PubMed  CAS  Google Scholar 

  • Bianchi R, Buyukakilli B et al (2004) Erythropoietin both protects from and reverses experimental diabetic neuropathy. PNAS 101(3):823–828

    Article  PubMed  CAS  Google Scholar 

  • Brines ML, Ghezzi P et al (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97(19):10526–10531

    Article  PubMed  CAS  Google Scholar 

  • Celik M, Gokmen N et al (2002) Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 99(4):2258–2263

    Article  PubMed  CAS  Google Scholar 

  • Chin K, Yu X et al (2000) Production and processing of erythropoietin receptor transcripts in brain. Brain Res Mol Brain Res 81(1–2):29–42

    Article  PubMed  CAS  Google Scholar 

  • Dame C, Bartmann P et al (2000) Erythropoietin gene expression in different areas of the developing human central nervous system. Brain Res Dev Brain Res 125(1–2):69–74

    Article  PubMed  CAS  Google Scholar 

  • Digicaylioglu M, Lipton SA (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412(6847):641–647

    Article  PubMed  CAS  Google Scholar 

  • Digicaylioglu M, Bichet S et al (1995) Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92(9):3717–3720

    Article  PubMed  CAS  Google Scholar 

  • Ehrenreich H, Hasselblatt M et al (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8(8):495–505

    PubMed  CAS  Google Scholar 

  • Ehrenreich H, Weissenborn K et al (2009) Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40(12):e647–e656

    Article  PubMed  CAS  Google Scholar 

  • Erbayraktar S, Grasso G et al (2003) Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity invivo. Proc Natl Acad Sci USA 100(11):6741–6746

    Article  PubMed  CAS  Google Scholar 

  • Feldman L, Wang Y et al (2006) Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Prostate 66(2):135–145

    Article  PubMed  CAS  Google Scholar 

  • Gorio A, Gokmen N et al (2002) Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci USA 99(14):9450–9455

    Article  PubMed  CAS  Google Scholar 

  • Grasso G (2001) Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J Neurosurg Sci 45(1):7–14

    PubMed  CAS  Google Scholar 

  • Grimm C, Wenzel A et al (2006) Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration. Adv Exp Med Biol 588:119–131

    Article  PubMed  Google Scholar 

  • Jeong J-Y, Feldman L et al (2008) Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells. Int J Cancer 122(2):274–280

    Article  PubMed  CAS  Google Scholar 

  • Jeong J-Y, Hoxhaj G et al (2009) An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells. Mol Cancer Res 7(7):1150–1157

    Article  PubMed  CAS  Google Scholar 

  • Junk AK, Mammis A et al (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 99(16):10659–10664

    Article  PubMed  CAS  Google Scholar 

  • Juul SE, Yachnis AT et al (1999) Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 2(2):148–158

    Article  PubMed  CAS  Google Scholar 

  • Koshimura K, Murakami Y et al (1999) Effects of erythropoietin on neuronal activity. J Neurochem 72(6):2565–2572

    Article  PubMed  CAS  Google Scholar 

  • Marti HH, Wenger RH et al (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8(4):666–676

    Article  PubMed  CAS  Google Scholar 

  • Masuda S, Nagao M et al (1993) Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 268(15):11208–11216

    PubMed  CAS  Google Scholar 

  • Masuda S, Okano M et al (1994) A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269(30):19488–19493

    PubMed  CAS  Google Scholar 

  • Morishita E, Masuda S et al (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76(1):105–116

    Article  PubMed  CAS  Google Scholar 

  • Nagai A, Nakagawa E et al (2001) Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol 60(4):386–392

    PubMed  CAS  Google Scholar 

  • Ruscher K, Freyer D et al (2002) Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22(23):10291–10301

    PubMed  CAS  Google Scholar 

  • Sadamoto Y, Igase K et al (1998) Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253(1):26–32

    Article  PubMed  CAS  Google Scholar 

  • Sakanaka M, Wen TC et al (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 95(8):4635–4640

    Article  PubMed  CAS  Google Scholar 

  • Sasaki R, Masuda S et al (2001) Pleiotropic functions and tissue-specific expression of erythropoietin. News Physiol Sci 16:110–113

    PubMed  CAS  Google Scholar 

  • Shingo T, Sorokan ST et al (2001) Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21(24):9733–9743

    PubMed  CAS  Google Scholar 

  • Siren AL, Fratelli M et al (2001a) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98(7):4044–4049

    Article  PubMed  CAS  Google Scholar 

  • Siren AL, Knerlich F et al (2001b) Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 101(3):271–276

    PubMed  CAS  Google Scholar 

  • Solar P, Feldman L et al (2008a) Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype. Int J Cancer 122(2):281–288

    Article  PubMed  CAS  Google Scholar 

  • Solar P, Koval J et al (2008b) Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells. Mol Cancer Ther 7:2263–2271

    Article  PubMed  CAS  Google Scholar 

  • Solar P, Koval J et al (2010) Erythropoietin and ovarian cancer—response. Mol Cancer Ther 9(4):1071

    Article  CAS  Google Scholar 

  • Stolze I, Berchner-Pfannschmidt U et al (2002) Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Blood 100(7):2623–2628

    Article  PubMed  CAS  Google Scholar 

  • Studer L, Csete M et al (2000) Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20(19):7377–7383

    PubMed  CAS  Google Scholar 

  • Sugawa M, Sakurai Y et al (2002) Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res 44(4):391–403

    Article  PubMed  CAS  Google Scholar 

  • Suzuki N, Ohneda O et al (2002) Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood 100(7):2279–2288

    Article  PubMed  CAS  Google Scholar 

  • Sytkowski AJ (2004) Erythropoietin: blood, brain and beyond. Wiley, Weinheim

    Book  Google Scholar 

  • Tan CC, Eckardt KU et al (1992) Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 263(3 Pt 2):F474–F481

    PubMed  CAS  Google Scholar 

  • Um M, Gross AW et al (2007) A “classical” homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell Signal 19(3):634–645

    Article  PubMed  CAS  Google Scholar 

  • Weber A, Maier RF et al (2002) Erythropoietin improves synaptic transmission during and following ischemia in rat hippocampal slice cultures. Brain Res 958(2):305–311

    Article  PubMed  CAS  Google Scholar 

  • Wustenberg T, Begemann M et al (2011a) EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: indication of areas with most progressive neurodegeneration inherent to the disease process. Mol Psychiatry 16(1):1

    Article  Google Scholar 

  • Wustenberg T, Begemann M et al (2011b) Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry 16(1):26–36

    Article  PubMed  CAS  Google Scholar 

  • Yu X, Shacka JJ et al (2002) Erythropoietin receptor signalling is required for normal brain development. Development 129(2):505–516

    PubMed  CAS  Google Scholar 

  • Zhang J, Wu Y et al (2008) Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 49(2):732–742

    Article  PubMed  Google Scholar 

  • Zhong L, Bradley J et al (2007) Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci 48(3):1212–1218

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology and Oncology Group, Oncology Therapeutic Delivery Unit, Quintiles Transnational, 203 Park Avenue, Arlington, MA, 02476, USA

    Arthur J. Sytkowski

  2. Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA, 02215, USA

    Arthur J. Sytkowski

Authors
  1. Arthur J. Sytkowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur J. Sytkowski.

Additional information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sytkowski, A.J. The Neurobiology of Erythropoietin. Cell Mol Neurobiol 31, 931–937 (2011). https://doi.org/10.1007/s10571-011-9695-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-011-9695-0

Keywords

Search

Navigation